DSG2 over-expression increased EV release. Cancer cell-derived EVs activated Erk1/2 and Akt pathways, and promoted proliferation in recipient fibroblasts. DSG2 C-terminal fragment and EGFR were up-regulated in HNSCC patient serum EVs. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.